Success Metrics

Active Trials

0(0%)

Phase Distribution

Ph phase_2

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

4(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 24 (100.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials

Showing 4 of 4

unknownphase_2

Clinical Trials (4)

Showing 4 of 4 trials

NCT00024375Phase 2

DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer

Unknown

NCT00024388Phase 2

Chemotherapy in Treating Patients With Metastatic Kidney Cancer

Unknown

NCT00024401Phase 2

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Unknown

NCT00024414Phase 2

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4